Cancer Genetics partners with AstraZeneca division

|About: Cancer Genetics, Inc. (CGIX)|By:, SA News Editor

Cancer Genetics (CGIX) inks a deal with AstraZeneca (AZN) CAMCAR, S.A. to provide biomarker-based diagnostic testing services for cancer patients in Central America and the Caribbean. The initial focus will be lung cancer but will eventually expand to other cancer categories.